Goals · Systems & Longevity
Organ protection during high-load protocols, detoxification support, fibrosis prevention.
Compounds linked to this goal in the catalogue, ordered by role — primary, then support, then optional. Roles follow peptide-db's per-use effectiveness rating (most effective → primary, effective → support, moderate or thinner → optional); a compound that reaches the goal through a curated stack or a condition page says so. Click any card for the full mechanism, dosing, and evidence.
L-Glutathione | Master Antioxidant Tripeptide
Half-life: ~10-14 minutes (IV)
Relaxin-2 Analog | Anti-Fibrotic & Cardiovascular
Half-life: Not well characterized
Support — Organ Fibrosis · effective
Senolytic Peptide | p53-FOXO4 Disruptor
Half-life: Not established
Support — Kidney Function · effective
KEDA Tetrapeptide | Liver Bioregulator
Half-life: Not established
Support — Hepatoprotection · effective
EDL Tripeptide | Liver & GI Bioregulator
Half-life: Not established
Support — Liver Fibrosis · effective
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Half-life: ~7 days (168 hours)
Support — Researched for Non-Alcoholic Fatty Liver (NAFLD)
Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator
Half-life: Under investigation (no human PK data)
Optional — Age-Related Kidney Disease · moderate
No SARMs tagged for this goal yet.
Mucolytic | Glutathione Precursor | FDA-Approved Drug
Half-life: ~6 hours (oral); plasma cysteine elevation persists ~12 hours
Angiotensin II Receptor Blocker | Cardiac Protection On Cycle
Half-life: ~24 hours
Support — Nephroprotection · effective